EUVIMEDEUVIMED entdecken
Open Access

Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment

José Javier Morales-Núñez, José Francisco Muñoz-Valle, Mariel García-Chagollán, Sergio Cerpa-Cruz, Gloria Esther Martínez-Bonilla, Vianey Monserrat Medina-Rosales, Saúl Alberto Díaz-Pérez iD, Ferdinando Nicoletti, Jorge Hernández-Bello iD

Clinical and Experimental Immunology · 13.12.2023 · 214 (3) · 314-327

DOI: 10.1093/cei/uxad076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 19.07.2023. Verfasst von José Javier Morales-Núñez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centro Universitario de Ciencias de la Salud, Doctorado en Ciencias Biomédicas, Universidad de Guadalajara, Jalisco, Mexico. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fondo Sectorial de Investigación para la Educación SEP, University of Guadalajara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Few studies analyze the role of B-cell subpopulations in rheumatoid arthritis (RA) pathophysiology. Therefore, this study aimed to analyze the differences in B-cell subpopulations and B-cell activation according to disease activity, RA subtype, and absence of disease-modifying antirheumatic drugs (DMARDs) therapy. These subgroups were compared with control subjects (CS). One hundred and thirty-nine subjects were included, of which 114 were RA patients, and 25 were controls. Patients were divided into 99 with seropositive RA, 6 with seronegative RA, and 9 without DMARDs. The patients with seropositive RA were subclassified based on the DAS28 index. A seven-color multicolor flow cytometry panel was used to identify B-cell immunophenotypes and cell activation markers. There were no changes in total B-cell frequencies between RA patients and controls. However, a lower frequency of memory B cells and pre-plasmablasts was observed in seropositive RA compared to controls (P < 0.0001; P = 0.0043, respectively). In contrast, a higher frequency of mature B cells was observed in RA than in controls (P = 0.0002). Among patients with RA, those with moderate activity had a higher percentage of B cells (P = 0.0021). The CD69+ marker was increased (P < 0.0001) in RA compared to controls, while the CD40+ frequency was decreased in patients (P < 0.0001). Transitional, naïve, and double-negative B-cell subpopulations were higher in seronegative RA than in seropositive (P < 0.01). In conclusion, in seropositive and seronegative RA patients, there are alterations in B-cell activation and B-cell subpopulations, independently of clinical activity and DMARDs therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntirheumatic AgentsHumansAutoantibodiesB-LymphocytesFlow Cytometry

Stichwörter der Autor:innen

B-cell subpopulationsCD40CD69DAS-28rheumatoid arthritis

Substanzen

AutoantibodiesAntirheumatic Agents

Autor:innen und Institutionen

  • Centro Universitario de Ciencias de la Salud, Doctorado en Ciencias Biomédicas, Universidad de Guadalajara, Jalisco, Mexico.
  • Centro Universitario de Ciencias de la Salud, Instituto de Investigación en Ciencias Biomédicas (IICB), Universidad de Guadalajara, Jalisco, Mexico.
  • Hospital Civil de Guadalajara "Fray Antonio Alcalde", Servicio de Reumatología, Jalisco, Mexico.
  • Centro Universitario de Ciencias de la Salud, Licenciatura en Médico, Cirujano y Partero, Universidad de Guadalajara, Jalisco, Mexico.
  • Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.

ORCID-Profile: Saúl Alberto Díaz-Pérez, Jorge Hernández-Bello

Förderung

  • Fondo Sectorial de Investigación para la Educación SEP
  • University of Guadalajara

Zitieren

APA

Morales-Núñez, J. J., Muñoz-Valle, J. F., García-Chagollán, M., Cerpa-Cruz, S., Martínez-Bonilla, G. E., Medina-Rosales, V. M., Díaz-Pérez, S. A., Nicoletti, F., & Hernández-Bello, J. (2023). Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment. Clinical and Experimental Immunology, 214(3), 314-327. https://doi.org/10.1093/cei/uxad076

Vancouver

Morales-Núñez JJ, Muñoz-Valle JF, García-Chagollán M, Cerpa-Cruz S, Martínez-Bonilla GE, Medina-Rosales VM, et al. Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment. Clinical and Experimental Immunology. 2023;214(3):314-327. doi:10.1093/cei/uxad076

BibTeX
@article{MoralesNez2023,
  author = {Morales-Núñez, José Javier and Muñoz-Valle, José Francisco and García-Chagollán, Mariel and Cerpa-Cruz, Sergio and Martínez-Bonilla, Gloria Esther and Medina-Rosales, Vianey Monserrat and Díaz-Pérez, Saúl Alberto and Nicoletti, Ferdinando and Hernández-Bello, Jorge},
  title = {Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment},
  journal = {Clinical and Experimental Immunology},
  year = {2023},
  volume = {214},
  number = {3},
  pages = {314--327},
  doi = {10.1093/cei/uxad076}
}
Kostenlos starten →